Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Sijbrands

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Atherosclerosis|June 14, 2017
Xanthomas and atheromasEric J Sijbrands
European Heart Journal|November 17, 2010
Towards individualized preventive therapyMaarten L Simoons, Eric J Sijbrands, Koen Nieman
Current Opinion in Lipidology|February 8, 2017
Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemiaMafalda Bourbon, Ana C Alves, Eric J Sijbrands
Diabetes Care|July 29, 2006
Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular diseaseAdrienne A M Zandbergen, Eric J Sijbrands, Steven W Lamberts, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Single-photon emission computed tomography for assessment of myocardial viabilityArend F L Schinkel, Roelf Valkema, Marcel L Geleijnse, et al.
Journal of Clinical Lipidology|May 17, 2017
Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experienceAnnette M H Galema-Boers, Mattie J Lenzen, Eric J Sijbrands, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 17, 2023
Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery DiseaseAlexander S F Berry, Laney K Jones, Eric J Sijbrands, et al.
Journal of Clinical Lipidology|February 6, 2018
Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapyAnnette M Galema-Boers, Mattie J Lenzen, Sophie R Engelkes, et al.
Scientific Reports|November 13, 2012
Characterization of coagulation factor synthesis in nine human primary cell typesMonireh Dashty, Vishtaseb Akbarkhanzadeh, Clark J Zeebregts, et al.
Journal of the American Geriatrics Society|April 20, 2017
Oxidized LDL, Gamma-Glutamyltransferase and Adverse Outcomes in Older AdultsBelinda Spoto, Francesco Mattace-Raso, Eric J Sijbrands, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Atherosclerosis|June 14, 2017
Xanthomas and atheromasEric J Sijbrands
European Heart Journal|November 17, 2010
Towards individualized preventive therapyMaarten L Simoons, Eric J Sijbrands, Koen Nieman
Current Opinion in Lipidology|February 8, 2017
Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemiaMafalda Bourbon, Ana C Alves, Eric J Sijbrands
Diabetes Care|July 29, 2006
Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular diseaseAdrienne A M Zandbergen, Eric J Sijbrands, Steven W Lamberts, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Single-photon emission computed tomography for assessment of myocardial viabilityArend F L Schinkel, Roelf Valkema, Marcel L Geleijnse, et al.
Journal of Clinical Lipidology|May 17, 2017
Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experienceAnnette M H Galema-Boers, Mattie J Lenzen, Eric J Sijbrands, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 17, 2023
Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery DiseaseAlexander S F Berry, Laney K Jones, Eric J Sijbrands, et al.
Journal of Clinical Lipidology|February 6, 2018
Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapyAnnette M Galema-Boers, Mattie J Lenzen, Sophie R Engelkes, et al.
Scientific Reports|November 13, 2012
Characterization of coagulation factor synthesis in nine human primary cell typesMonireh Dashty, Vishtaseb Akbarkhanzadeh, Clark J Zeebregts, et al.
Journal of the American Geriatrics Society|April 20, 2017
Oxidized LDL, Gamma-Glutamyltransferase and Adverse Outcomes in Older AdultsBelinda Spoto, Francesco Mattace-Raso, Eric J Sijbrands, et al.
Pageof 4